Centrally-acting opioid receptor antagonists as a treatment for antipsychotic-induced weight gain: A systematic review and meta-analysis of clinical trial data
PsiquiatriaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Journal of psychopharmacology (Oxford, England)
- Publicado em
- 23 mai 2025
- Citações
- 3
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Centrally-acting opioid receptor antagonists as a treatment for antipsychotic-induced weight gain: A systematic review and meta-analysis of clinical trial data
Kenn Lee, Matthew Twohig, Nguemo Pauline Idoko, Benjamin David Williams
Descritores MeSH
- Naltrexone
- Antipsychotic Agents
- Weight Gain
- Narcotic Antagonists
- Randomized Controlled Trials as Topic
- Humans
- Schizophrenia
- Olanzapine
Veja também
Estudos relacionados
- Olanzapine/Samidorphan Effects on Weight Gain: An Individual Patient Data Meta-Analysis of Phase 2 and 3 Randomized Double-Blind Studies
- A meta-analysis comparing short-term weight and cardiometabolic changes between olanzapine/samidorphan and olanzapine
- The Efficacy of Olanzapine/Samidorphan on Negative Symptoms: A Post Hoc Analysis of 56-Week Treatment in Patients With Schizophrenia
- Olanzapine/Samidorphan in Young Adults With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder Who Are Early in Their Illness: Results of the Randomized, Controlled ENLIGHTEN-Early Study